Fast Tracked PMCF Activities
This case study looks at fast tracked PMCF activities and how CLIN-r+ supported one manufacturer with their Clinical Data Acquisition for EU MDR submission from an MDD Certificate based on Equivalence.
This case study looks at fast tracked PMCF activities and how CLIN-r+ supported one manufacturer with their Clinical Data Acquisition for EU MDR submission from an MDD Certificate based on Equivalence.
The CE mark is a major milestone for most medical devices. It can take a long time to obtain and be a challenging process. CLIN-r+ looks at the manufacturer responsibilities once the CE mark has been granted, update requirements, and more.
The EU MDR increases the need for Post Market Surveillance (PMS), and therefore Post Market Clinical Follow up (PMCF). CLIN-r+ explains how manufacturers will need to collect more clinical evidence and improve data quality and management for each device.
Clin-r+ outlines the requirements and considerations manufacturers should review to ensure that Clinical Investigations they undertake are well researched to ensure a return on investment.
The EU MDR has raised the bar for supporting data quantity and quality, so it is critical to keep the pace of preparation activities in Post-Market Clinical Follow-Up planning. This document provides manufacturers with best practice guidance for preparation, steps, and the three key pitfalls which CLIN-r+ frequently encounters.
We provide services globally, so reach out via this contact page and we will reach out to you, within 12 hours to discuss how we can help.